Show simple item record

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021

dc.contributor.authorStarrfelt, Jostein
dc.contributor.authorDanielsen, Anders Skyrud
dc.contributor.authorBuanes, Eirik Alnes
dc.contributor.authorJuvet, Lene Kristine
dc.contributor.authorLyngstad, Trude Marie
dc.contributor.authorRø, Gunnar Øyvind Isaksson
dc.contributor.authorVeneti, Lamprini
dc.contributor.authorWatle, Sara Sofie Viksmoen
dc.contributor.authorMeijerink, Hinta
dc.date.accessioned2022-11-09T09:17:59Z
dc.date.available2022-11-09T09:17:59Z
dc.date.created2022-10-17T09:49:51Z
dc.date.issued2022
dc.identifier.citationBMC Medicine. 2022, 20 (1), 1-11.
dc.identifier.issn1741-7015
dc.identifier.urihttps://hdl.handle.net/11250/3030849
dc.language.isoeng
dc.titleAge and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
dc.title.alternativeAge and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-11
dc.source.volume20
dc.source.journalBMC Medicine
dc.source.issue1
dc.identifier.doi10.1186/s12916-022-02480-4
dc.identifier.cristin2061851
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Files in this item

Thumbnail
Name:
Starrfelt_2022_Age.pdf
Size:
1.184Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record